SL BIGEN

SL BIGEN is a R&D-oriented company, with an aim to Save patient's Lives By Bio-Genetic ENgineering... SL BIGEN is developing (i) the first-in-class mesenchymal stem cell line engineered to express disease-specific therapeutic genes and (ii) the multi-engineered natural killer cell line expressing the fourth generation chimeric antigen receptors. Our therapeutic areas include cancer and neurodegenerative diseases.

Primary location: Incheon South Korea